Coronavirus disease (COVID-19) is an infectious disease caused by the coronavirus SARS-CoV-2. Here we have collected APR news related to the COVID-19 pandemic, vaccination efforts and emerging treatments.
Valneva announced that the European Commission (EC) approved an amendment to the Advance Purchase Agreement (APA) signed in November 2021 for Valneva’s inactivated whole-virus COVID-19 vaccine, ...
read more
Novavax, Inc. announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received emergency use authorization (EUA) from the FDA to provide a two-dose primary series for active ...
read more
Novavax, Inc. announced an agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, to secure an initial 3.2 million doses of Novavax' ...
read more
COVID-19 vaccine acceptance increased 3.7% between 2020 and 2021, according to a new study from researchers at the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), the Barcelona ...
read more
CEPI, the Coalition for Epidemic Preparedness Innovations, and Codiak BioSciences announced the latest funding award under CEPI’s US $200m program to advance the development of vaccines that provide ...
read more
Ascletis Pharma Inc. annunced that the Investigational New Drug (IND) application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for Coronavirus Disease 2019 ...
read more
Pfizer and BioNTech announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent, a ...
read more
Merck announced that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) unanimously voted to include VAXNEUVANCETM (Pneumococcal 15-...
read more
Valneva SE announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization in Europe for Valneva’s inactivated ...
read more
Following a thorough review of COVID Alert, the Government of Canada has decommissioned the application effective June 17, 2022. The exposure notification service is disabled and users can delete the ...
read more
Following a successful vaccination campaign, 32 million (or nearly 90%) of eligible Canadians have been vaccinated against COVID-19 and case counts have decreased.
read more
Novavax, Inc. announced that the Australian Therapeutic Goods Administration (TGA) has granted provisional registration of Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine as a booster in individuals aged 18...
read more
Pfizer Inc. will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its ...
read more
The COVID pandemic brought mRNA vaccines to the forefront of innovation and progress in therapeutical medicine with the rapid release of highly efficacious (93–95%) vaccines by BioNTech/Pfizer and ...
read more
Viruses are found in almost every ecosystem on Earth and are the most numerous types of biological entity. As such, viruses pose a challenge to many aspects of biopharmaceutical manufacturing. These ...
read more